Obinutuzumab in Marginal Zone Lymphoma
Obinutuzumab in Marginal Zone Lymphoma
Active, not recruiting · NCT03322865 · Registry updated 2026-05-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Obinutuzumab in Marginal Zone Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, neoplasm | Active, not recruiting | Phase 2 | 2026-05-06 | NCT03322865 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Christian Buske | 5 |
| Optimapharm | 3 |
| Roche Pharma AG | 59 |
| University of Ulm | 46 |
| X-act Cologne Clinical Research GmbH | 3 |
| Zentrum für Klinische Studien Ulm | 4 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Augusta-Kranken-Anstalt gGmbH | Bochum | Germany | 2 |
| Gemeinschaftspraxis für Hämatologie und Onkologie | Münster | Germany | 1 |
| Institut für Versorgungsforschung GbR | Koblenz | Germany | 1 |
| Klinikum Passau | Passau | Germany | 6 |
| University Hospital Essen | Essen | Germany | 14 |
| University Hospital Halle | Halle | Germany | 4 |
| University Hospital Mainz | Mainz | Germany | 1 |
| University Hospital Münster | Münster | Germany | 12 |
| University Hospital Ulm | Ulm | Germany | 17 |
| Universitätsklinikum Freiburg | Freiburg im Breisgau | Germany | 34 |
| Universitätsklinikum Mannheim | Mannheim | Germany | 21 |
| Universitätsmedizin Georg-August-University | Göttingen | Germany | 1 |